To Compare: The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics. Concept introduction: Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Question

Want to see more full solutions like this?

Answer 1

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 2

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 3

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 4

Question

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!

Answer 5

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 6

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.

Conclusion

Thus, the coagulation modifiers are responsible for promoting or preventing the formation of blood clots.

Answer 7

Chapter 26, Problem 1O

Summary Introduction

To Compare:

The coagulation process and the impact of coagulation modifier include anticoagulants, antiplatelet, thrombolytic, and antifibrinolytics.

Concept introduction:

Coagulation is otherwise called clotting. In this clotting process, the blood changes to gel from liquid. The forming of blood clot results in hemostasis. Generally, the clotting of blood occurs when the blood vessels are damaged. The protein is the coagulation process that is numbered by the Roman numerals from I- XIII. Some of the coagulation factors are II, VII, IX, and X, where all are produced in the liver except VIII.

Answer 8

Expert Solution & Answer

Explanation of Solution

Impact of coagulation modifier:

The coagulation modifier is the drug that takes action on the blood coagulation pathway to prevent or develop the formation of a clot. The coagulation modifiers are anticoagulants, antiplatelet drug, and thrombolytic drug.

Anticoagulants:

The anticoagulants prevent the formation of clotting factors and also avoid the formation of clots. The action of anticoagulant varying from one drug to another drug and the anticoagulant therapy are used for treating thrombosis.

Antiplatelet:

The antiplatelet blocks the platelet plugs from forming and preventing platelet aggregations. This process can be helpful in avoiding heart attack and strokes. Some of the antiplatelets include clopidogrel, dipyridamole, and ticlopidine.

Thrombolytic drug:

The important difference between thrombolytic and anticoagulant is to prevent the formation of blood clots. The thrombolytic drugs break the clots that are already present in the vessels. The thrombolytic is used as the injection to bust the clots by an intravenous line.

Antifibrinolytics drugs:

The hemostatic drug is otherwise called the antifibrinolytics drug that possesses the opposite effect when compared to the other class of drugs. This is mainly involved in promoting blood coagulation.